Literature DB >> 9015411

Determinants of coronary reserve in rats subjected to coronary artery ligation or aortic banding.

E A Kalkman1, Y M Bilgin, P van Haren, R J van Suylen, P R Saxena, R G Schoemaker.   

Abstract

OBJECTIVE: We investigated whether decreased coronary reserve in hearts after coronary artery ligation or in hearts from rats after aortic banding can be related to remodeling of resistance arteries.
METHODS: Maximal coronary flow (absolute flow) and cardiac perfusion (flow corrected for heart weight) were determined in isolated, perfused rat hearts after adenosine or nitroprusside, at 3 and 8 weeks after coronary artery ligation or 4-5 weeks after aortic banding. Perivascular collagen and medial thickness of resistance arteries were determined by morphometry.
RESULTS: maximal coronary flow of infarcted hearts had been restored to sham values at 3 weeks. Growth of cardiac muscle mass from 3 to 8 weeks exceeded the increase in maximal coronary flow, leading to a decreased perfusion at 8 weeks. A slight, transient increase in perivascular collagen, but no medial hypertrophy, was found after infarction. After aortic banding perivascular fibrosis and medial hypertrophy led to a decreased maximal coronary flow in both the hypertrophied left and the non-hypertrophied right ventricle. Consequently, perfusion of the left ventricle was most severely reduced.
CONCLUSIONS: Reduced maximal perfusion after aortic banding is determined by both cardiac hypertrophy and vascular remodeling. In contrast, during infarction-induced remodeling, reduction of perfusion is not determined by vascular remodeling, but mainly by disproportional cardiac hypertrophy relative to vascular growth.

Entities:  

Mesh:

Year:  1996        PMID: 9015411     DOI: 10.1016/s0008-6363(96)00166-6

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  16 in total

1.  Augmentation of coronary conductance in adult sheep made anaemic during fetal life.

Authors:  L Davis; J B Roullet; K L Thornburg; M Shokry; A R Hohimer; G D Giraud
Journal:  J Physiol       Date:  2002-10-18       Impact factor: 5.182

Review 2.  Myocardial neovascularization by adult bone marrow-derived angioblasts: strategies for improvement of cardiomyocyte function.

Authors:  Silviu Itescu; Alfred A Kocher; Michael D Schuster
Journal:  Heart Fail Rev       Date:  2003-07       Impact factor: 4.214

Review 3.  The effects of anaemia as a programming agent in the fetal heart.

Authors:  L Davis; K L Thornburg; G D Giraud
Journal:  J Physiol       Date:  2005-03-10       Impact factor: 5.182

4.  Tl-201 washout rate in remote normal regions in patients with prior myocardial infarction and left ventricular remodeling.

Authors:  Toshihiko Goto; Nobuyuki Ohte; Hiromichi Miyabe; Seiji Mukai; Seiichiro Sakata; Junichiro Hayano; Genjiro Kimura
Journal:  J Nucl Cardiol       Date:  2005 Mar-Apr       Impact factor: 5.952

5.  Impaired myocardial oxidative metabolism in the remote normal region in patients in the chronic phase of myocardial infarction and left ventricular remodeling.

Authors:  Nobuyuki Ohte; Hitomi Narita; Akihiko Iida; Kazuaki Wakami; Kaoru Asada; Hidekatsu Fukuta; Takafumi Kato; Junichiro Hyano; Genjiro Kimura
Journal:  J Nucl Cardiol       Date:  2009-01-20       Impact factor: 5.952

6.  Myocardial perfusion imaging using a non-contrast agent MR imaging technique.

Authors:  C Waller; K H Hiller; S Voll; A Haase; G Ertl; W R Bauer
Journal:  Int J Cardiovasc Imaging       Date:  2001-04       Impact factor: 2.357

7.  Early increase in myocardial perfusion after stem cell therapy in patients undergoing incomplete coronary artery bypass surgery.

Authors:  Luís Henrique Wolff Gowdak; Isolmar Tadeu Schettert; Carlos Eduardo Rochitte; Luiz Augusto Ferreira Lisboa; Luís Alberto Oliveira Dallan; Luiz Antônio Machado César; Sérgio Almeida de Oliveira; José Eduardo Krieger
Journal:  J Cardiovasc Transl Res       Date:  2011-02       Impact factor: 4.132

Review 8.  New directions in strategies using cell therapy for heart disease.

Authors:  Silviu Itescu; Michael D Schuster; Alfred A Kocher
Journal:  J Mol Med (Berl)       Date:  2003-04-16       Impact factor: 4.599

Review 9.  Therapeutic potential of erythropoietin in cardiovascular disease: erythropoiesis and beyond.

Authors:  B Daan Westenbrink; Adriaan A Voors; Willem-Peter T Ruifrok; Wiek H van Gilst; Dirk J van Veldhuisen
Journal:  Curr Heart Fail Rep       Date:  2007-09

10.  Low coronary driving pressure early in the course of myocardial infarction is associated with subendocardial remodelling and left ventricular dysfunction.

Authors:  Marcia Kiyomi Koike; Clovis De Carvalho Frimm; Mariana Cúri
Journal:  Int J Exp Pathol       Date:  2007-08       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.